Minimal residual disease (MRD) testing in leukemia — what parents need to know
Medically reviewed by CION Oncology Team · Last reviewed June 2026
Your child’s oncologist has mentioned MRD testing, and you want to understand what it means. MRD stands for minimal residual disease — it is a highly sensitive way of tracking how well leukemia treatment is working. This page explains what MRD testing is, what the results mean, and how the team at CION uses this information to guide your child’s care.
- More sensitive than routine blood tests — the MRD leukemia test can detect one cancer cell among tens of thousands of normal cells.
- Guides treatment decisions — MRD results help the team decide whether to continue, intensify, or adjust therapy.
- MRD negative is encouraging — it means no leukemia cells are detectable at that moment, a positive sign that treatment is working.
- Tumor board for every patient — at CION, MRD results are reviewed by the full oncology team, not a single doctor.
on Panel
Survival Rate*
Treated
(800+ reviews)
What is minimal residual disease (MRD) and why does it matter for your child?
When a child is diagnosed with leukemia, the first goal of treatment is to bring the cancer into remission — a state where no leukemia cells are visible under a standard microscope. But leukemia cells are often far more numerous and far more stubborn than a microscope can reveal. That is where MRD testing comes in.
Minimal residual disease refers to the small number of leukemia cells that may remain in the body after treatment — too few to be seen on a routine blood count or bone marrow examination, but potentially enough to cause a relapse later if left unaddressed. An MRD test is designed to detect these remaining cells at a level of sensitivity that standard tests cannot achieve.
Think of it this way: a conventional bone marrow examination can spot roughly one leukemia cell among every hundred normal cells. An MRD test using flow cytometry can find one leukemia cell among ten thousand normal cells, and a molecular PCR-based MRD test can go even further. This matters because the earlier any remaining disease is found, the sooner the treatment plan can be adjusted.
Important for parents: An “MRD negative” result does not mean your child is cured. It means that at the time of testing, no leukemia cells were detectable at the level the test can measure. It is a very positive sign, but monitoring continues throughout the treatment course and beyond. Your oncologist will explain what the result means specifically for your child.
MRD monitoring is now a standard part of treatment for childhood acute lymphoblastic leukemia (ALL) and is increasingly used in childhood acute myeloid leukemia (AML). The result at key time points during treatment is one of the most important markers doctors use to understand how well therapy is working and to decide whether any changes are needed.
MRD negative meaning — what parents ask most
MRD negative means no leukemia cells were found at the level the test can detect. This is the result treatment teams aim for, particularly after the early weeks of chemotherapy (induction) and at the end of the consolidation phase. Achieving MRD negativity early in treatment is associated with a lower risk of the leukemia coming back — though this does not guarantee anything, and your child will continue to be monitored closely.
MRD positive means some leukemia cells are still detectable. A positive result does not mean treatment has failed. It may mean the current approach needs to be intensified, or that the team will look at additional options. Every child’s situation is different. The level of MRD positivity (whether it is low or high) and whether it is falling or stable over time are all considered when interpreting results.
Flow cytometry MRD
The most widely used method. The bone marrow or blood sample is labelled with fluorescent markers that attach to proteins on the surface of cells. A machine then identifies leukemia cells by their abnormal surface pattern. Results are usually available within two to four days and can detect down to one leukemia cell in ten thousand.
PCR-based (molecular) MRD
Uses polymerase chain reaction to amplify and detect specific DNA or RNA sequences unique to your child’s leukemia clone. It can achieve even greater sensitivity than flow cytometry in some cases. Results typically take one to two weeks. It is especially useful where a specific genetic rearrangement was identified at diagnosis.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Your child’s MRD result needs expert interpretation
Our tumor board reviews every paediatric leukemia case — not one doctor’s opinion. We walk this journey with you.
How MRD is measured — what happens at each stage
Here is what the process looks like from the point your child’s doctor orders an MRD test, through to receiving and acting on the result. Every step is the same whether the test is done for the minimal residual disease test at the end of induction or at a later monitoring point.
-
Bone marrow aspiration — collecting the sample
The sample for MRD testing in leukemia almost always comes from the bone marrow, because that is where blood cells are made and where leukemia cells tend to accumulate. A bone marrow aspiration is performed: a thin needle is inserted into the back of the hip bone (posterior iliac crest) and a small amount of liquid marrow is drawn out.
In children, this is done under general anaesthesia or deep sedation — your child will be completely asleep. The procedure takes about 15 to 20 minutes, and most children go home the same day. Mild soreness at the site for a day or two is normal.
-
Sample preparation in the laboratory
The marrow sample is sent immediately to the laboratory, where it is processed to separate different types of cells. For flow cytometry MRD, the cells are stained with fluorescent antibodies that bind to specific proteins on cell surfaces. For PCR-based MRD, the DNA or RNA is extracted and amplified. The right method to use will have been decided at the time of diagnosis, based on what type of leukemia your child has and what genetic marker is being tracked.
-
Analysis — looking for leukemia cells
For flow cytometry, a machine analyses hundreds of thousands of cells at high speed, measuring the light each cell emits when it passes through a laser. The software identifies any cells that match the abnormal pattern seen in your child’s leukemia at diagnosis. For PCR-based MRD, the laboratory looks for the presence or absence of the specific genetic sequence identified at diagnosis, and if present, measures how much of it there is.
-
The result — what the numbers mean
The result is expressed as a number: for example, “MRD 0.01%” means that 1 in every 10,000 cells analysed was a leukemia cell. “MRD undetectable” or “MRD negative” means no leukemia cells were found at the sensitivity level of the test.
Flow cytometry results are usually ready in two to four days. PCR-based results may take one to two weeks. Your oncologist will call you as soon as the result is available to discuss what it means in the context of your child’s full treatment picture.
-
Tumor board review and next steps
At CION, every paediatric leukemia MRD result is reviewed by the full multidisciplinary tumor board — medical oncologists, haematologists, and other relevant specialists together. This means the decision about what to do next is never one person’s judgment.
If the MRD result is negative, the current treatment plan is likely to continue as scheduled. If MRD is positive — particularly if it is above a threshold that signals higher risk — the team will discuss whether to intensify therapy, switch to a different approach, or evaluate further options. Your oncologist will explain the recommendation at your next consultation, with time for your questions. Decisions for healing, not billing.
You walk into CION with a report. You walk out with a plan.
45-minute consultations. Tumor board for every patient. No unnecessary tests. We walk this journey with you.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Your questions about MRD testing in childhood leukemia — answered
What does "MRD negative" mean for my child?
MRD negative means that the most sensitive tests available cannot detect any remaining leukemia cells in your child’s bone marrow or blood at that moment. It does not mean the leukemia is definitely gone forever, but it is a very encouraging sign. Doctors use MRD negativity as a key marker that treatment is working well. Your oncologist will explain how your child’s MRD result fits into the overall treatment plan, and monitoring will continue at regular intervals throughout therapy. MRD status is one important piece of information among several that guide decisions — it is interpreted alongside your child’s specific leukemia type, genetics, and clinical response.
What is the minimal residual disease test and how is it done?
A minimal residual disease test is a highly sensitive laboratory analysis of a bone marrow or blood sample. After a bone marrow aspiration is collected (usually under sedation or general anaesthesia in children), the sample is analysed using flow cytometry or a molecular technique called PCR. Flow cytometry identifies abnormal leukemia cells by their surface markers — it can find as few as one leukemia cell among 10,000 normal cells. PCR looks for specific genetic changes unique to your child’s leukemia. The method used depends on the type of leukemia and what genetic changes were identified at diagnosis.
When during treatment is MRD measured?
In most leukemia treatment protocols, MRD is checked at specific points during the early phase of treatment — typically after the first four to six weeks of induction chemotherapy, and again at the end of consolidation. The exact schedule depends on the type of leukemia (ALL or AML), the treatment protocol being followed, and your child’s individual risk group. Your oncologist will tell you exactly when MRD checks are planned for your child. Some centres also monitor MRD during maintenance or after transplant to detect early signs of the leukemia returning.
What happens if MRD is still positive after treatment?
A positive MRD result means that some leukemia cells are still detectable. It does not automatically mean treatment has failed, but it does prompt the team to look carefully at the next steps. Depending on the level of MRD, the type of leukemia, and the timing of the test, the oncologist may intensify treatment, change to a different treatment approach, or recommend a bone marrow transplant. The decision is always made by a tumor board — a team of specialists reviewing the full picture together, not a single doctor’s judgment. Your oncologist will walk you through the options at your consultation.
Is the bone marrow aspiration for MRD painful for children?
In children, bone marrow aspiration — the procedure used to collect the sample for MRD testing — is almost always performed under general anaesthesia or deep sedation. Your child will be completely asleep and will not feel or remember the procedure. Afterwards, there may be mild soreness at the needle site (usually in the hip bone area) for a day or two, which is managed with simple pain relief. The procedure itself takes about 15 to 20 minutes, and most children go home on the same day. Your team will give you specific instructions on what to expect and how to care for the site at home.
Can MRD be measured from a blood sample instead of bone marrow?
For some types of leukemia, particularly certain forms of acute lymphoblastic leukemia (ALL), a peripheral blood sample can provide useful MRD information at specific time points. However, bone marrow remains the gold standard for most MRD assessments because leukemia cells are present in much higher concentrations there, making the test more accurate. Whether a blood-based MRD test is appropriate for your child depends on the leukemia type and what your treatment centre offers. Your oncologist will choose the most accurate and clinically meaningful method for your child’s specific situation.
Have a question not answered here? Call us on 1800 202 8726 or book a free consultation and our pediatric oncology team will answer every question you have.
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.